Scientific research fuels progress across many fields and industries. However, the very tools that enable these advancements—assays, kits, and reagents—can harbor inconsistencies. Inconsistent or low-quality materials can distort results even when experiments are conducted under seemingly identical conditions, leading to wasted time and resources. This issue has given rise to the reproducibility crisis, which refers to the growing recognition that many scientific studies cannot be reliably replicated, highlighting a critical need for robust practices in sourcing and managing these essential tools.
Combating these challenges requires a collaborative effort from both vendors and researchers. Vendors must prioritize transparency, providing detailed information about the provenance and quality of their products. In turn, researchers should critically assess vendor offerings based on reputation, quality control measures, and product specifications. This approach fosters trust and ensures researchers have the information they need to make informed decisions.
For more specialized research needs, custom kits can offer advantages. These kits can be tailored to specific experiments or targets, potentially leading to more streamlined workflows. However, careful consideration must be given to their development and integration.
By adopting best practices for sourcing and managing assays, kits, and reagents, labs can reduce variability and enhance the reliability of their research. This proactive approach not only strengthens scientific integrity but also contributes to more efficient operations, ultimately accelerating scientific discovery.
Download this eBook to learn more about:
- What to look for when purchasing assays, kits, and reagents
- How to identify reputable and transparent vendors
- Best practices for selecting and validating reagents
- Key considerations for acquiring custom kits
69169_LM_Assays, Kits & Reagents_eBook_JL V2
ASSAYS, KITS, AND REAGENTS RESOURCE GUIDE
Strategic Sourcing and Management of Assays, Kits, and Reagents
Best practices for enhancing research reliability and efficiency
ENSURING TRANSPARENCY
in kits and reagents
STRATEGIES
for selecting reputable vendors
ADVANTAGES
of custom kits
Table of Contents
3 Ensuring Quality and Consistency in Scientific Research
5 Questions to Ask When Buying Assays, Kits, and Reagents
7 Navigating Muddy Waters: Transparency in Commercial Kits and Reagents
11 Tips for Selecting Reputable Reagent Vendors
13 Best Practices for Choosing and Validating Reagents
15 How to Select the Right Antibodies for Your Research
2 Lab Manager
18 Considerations for Acquiring Custom Kits
Introduction
Ensuring Quality and Consistency in Scientific Research
Navigating the challenges of sourcing and managing assays, kits, and reagents
Scientific research fuels progress across many fields and industries. However, the very tools that enable these advancements-assays, kits, and reagents-can harbor inconsistencies.
Inconsistent or low-quality materials can distort results even when experiments are conduct- ed under seemingly identical conditions, leading to wasted time and resources. This issue has given rise to the reproducibility crisis, which refers to the growing recognition that many
scientific studies cannot be reliably replicated, highlighting a critical need for robust practices in sourcing and managing these essential tools.
Combating these challenges requires a collaborative effort from both vendors and researchers. Vendors must prioritize transparency, providing detailed information about the provenance and quality of their products. In turn, researchers should critically assess vendor offerings based on reputation, quality control measures, and product specifications. This approach fosters trust and ensures that researchers have the information they need to make informed decisions.
Introduction
Ensuring quality and consistency extends beyond the initial purchase. Once high-quality materials are secured, robust quality assurance practices that verify product performance are essential. This includes reagent validation, documentation of protocols and results, and regular training of lab personnel. These practices ensure continued reliability and minimize the risk of errors.
For more specialized research needs, custom kits can offer advantages. These kits can be tailored to specific experiments or targets, potentially leading to more streamlined workflows. However, careful consideration must be given to their development and integration.
By adopting these best practices for sourcing and managing assays, kits, and reagents, labs can reduce variability and enhance the reliability of their research. This proactive approach not only strengthens scientific integrity but also contributes to more efficient operations, ulti- mately accelerating scientific discovery.
This eBook covers essential topics to support lab managers in purchasing assays, kits, and reagents, navigating transparency in commercial kits and reagents, identifying reputable vendors, selecting and validating reagents, and acquiring custom kits.
Questions to Ask When Buying Assays, Kits, and Reagents
by Lab Manager
Thhen managing a lab, purchasing assays, kits, and reagents that meet your lab's needs is crucial for the efficiency and reli- ability of your research. The following questions are designed to help you make an informed purchasing decision that maxi- mizes cost-effectiveness and upholds scientific rigor.
Nine questions to ask when buying assays, kits, and reagents
1
What level of purity is required for your application?
2
Is the assay, kit, or reagent compatible with your existing lab equipment?
3
Does the assay, kit, or reagent streamline lab proce- dures and reduce processing time?
4
Can the reagents in the kit be purchased separately, or will you have to purchase a new kit if you run out of a component?
5
What is the unit price per test or sample?
6
What is the product's shelf life?
7
What storage conditions are required?
8
Purchasing Tip
Consider implementing a just-in-time inventory system for purchasing. This strategy involves ordering smaller quantities more frequently, based on regular assessments of your lab's usage rates. This can decrease the risk of reagent expiration and minimize storage needs, thereby reducing costs. Always check the lead times and minimum order quantities with your suppliers to ensure this approach doesn't disrupt your lab's operational efficiency.
Does the product comply with the relevant industry standards and regulatory requirements, such as ISO certification?
9
How sustainable are the production and packaging methods?
Navigating Muddy Waters: Transparency in Commercial Kits and Reagents
Transparency is a core tenant of scientific research yet remains absent. Recent progress lights a path forward
by Rachel Brown, MSc
A lack of transparency has contributed to the reproducibility crisis in science, spurring a suite of new reporting guidelines and publication expectations. The scientific community has mobilized around these concerns, and major progress has been and continues to be made.
Commercial reagents and kits carry additional challenges for transparency in provenance, quality, and proprietary formu- lations, however, and have been slower to respond to these pressures. Recently, though, real progress has been demon- strated with community-driven solutions and bold new open
science initiatives by leading companies, showing a potential route forward.
Commercial reagents in research
Commercial kits and reagents have fueled progress in the life sciences, enabling greater consistency between labs and drastic increases in throughput. They represent major tech- nological advances and have introduced new capabilities and opportunities for many labs.
They are also proprietary-with undisclosed formulations- and frequently transient in nature, appearing, disappearing, being rebranded, and moving across company catalogs. This makes them challenging for researchers to evaluate and nearly impossible to independently troubleshoot or modify protocols. Good suppliers will assist users, but challenging samples or applications frequently fall outside a company's support capabilities. Other companies are less responsive.
Thithout adequate knowledge of assay or reagent compo- nents, researchers can be left frustrated, relegated to either working blind, creating assays in-house, or modifying manu- al methodologies.
In addition, consumers worry about missing or misleading reagent descriptions and counterfeit reagents consisting of diluted, low-quality, or falsely repackaged reagents.
The problems surrounding reproducibility and transparen- cy in science are multifaceted, extensive, and impactful. A seminal paper by Begley and Ellis reported an inability to reproduce the findings of 46 out of 53 "landmark" preclinical studies, noting that some non-reproducible studies launched new fields of research and/or clinical studies. Concerns over the reliability of commercial reagents and kits form just one front, but it is a big one-forming an estimated $1.75 billion annual loss in research funds from non-specific antibodies alone. Researchers, commercial reagent suppliers, and third parties all have a role to play in the solution.
Antibodies as a case study for progress
Antibodies have been a lightning rod for reproducibility complaints, given the extent of the problem and dire con- sequences. Many reports describe commercial antibodies binding to unexpected and unrelated targets, with low or no affinity for the marketed antigen. The best cases end in wasted time and money-one lab reported two years and
$500,000 lost. In the worst cases, erroneous findings are
unwittingly published, leading entire fields astray, or causing serious medical complications in clinical use.
A unified front of researchers, institutes, non-profit orga- nizations, and commercial manufacturers against a shared problem has led to clear improvements, demonstrating the power of the community. As such, the effort behind improv- ing the reliability and use of antibodies can form a blueprint for continued progress.
The role of researchers
Researchers are ultimately responsible for verifying the per- formance of all kits and reagent lots for their use conditions and samples using appropriate controls. More extensive vali- dation is required for reagents that do not come with reliable data on the given application, parameters, and sample type.
Control runs are required for every test. Most reagents, an- tibodies included, have a shelf-life and deteriorate over time or freeze-thaw cycles. Additional performance issues can arise from shipping conditions, inappropriate storage during delivery or within the lab, or contamination during use.
Assessing the quality or reliability of a reagent prior to purchase is challenging. Purchasing directly from trusted manufacturers is advised, but a complex distribution network across suppliers, manufacturers, or distributors obscures
a reagent's provenance. Researchers can ask suppliers if they've made, tested, or renamed the reagent lot and request associated data. Reviewing the literature for use and vali- dation data is also recommended, but "junk-data avalanches through the literature", with unreliable reagents rendering the number of citations meaningless in assessing quality. Re- agent databases, which largely started around antibodies but are expanding in scope, offer researchers a starting point in their search. These databases are far from complete and do not rank reagents on validation or performance, so vigilance and critical assessment of data quality are still required.
Antibodies must show specificity, sensitivity, and reproduc- ibility within each application used. A highly cited protocol for antibody validation encourages the use of knockout cells as negative controls wherever possible to demonstrate both sensitivity and specificity, with tests repeated between lots to demonstrate reproducibility.
The response of manufacturers to performance complaints ranges from no response to refunds or changes to their
catalog, expanding high-performing antibody product lines, or discontinuing poor performers. This emphasizes the need to find and establish relationships with trusted providers who support their products and are willing to work with you.
The role of suppliers
Commercial reagent suppliers should provide documentation on reagent characterization or validation for recommended applications and usage with quality control (QC) documen- tation for every lot.
For antibodies, documentation should identify the source of reference material and validation method as well as per- formance characteristics including sensitivity, specificity, reproducibility, repeatability, likely sources of interference, and all known potential cross-reactivity. Exceptional suppli- ers may provide a full description of validation protocols for all major applications, lot comparisons, extensive test data, and verification across cell panels, controls, and treatments, demonstrating localization and treatment effect.
Validating every reagent against every possible application or sample type would be unrealistic and cost-prohibitive. Supporting third-party testing, as described below, introduc- es a cost-sharing model, making extensive characterization more feasible.
Thhile commercial organizations must protect intellectual property and appease stakeholders, publishing non-sensitive information regarding reagents would benefit research and expand usability. As one researcher suggests, "knowing the composition of the reaction medium does not eliminate the need to purchase the enzyme."
Obfuscation of original manufacture details, as described by both manufacturer and researcher, generates confusion and erodes trust. Greater transparency on the origin of a reagent and its QC documentation would likely require adjustments to OEM marketing agreements and business practices but would engender greater confidence.
Further, pharmaceutical organizations have demonstrated how sharing compounds without restrictions can benefit all parties and accelerate scientific progress, laying out a clear role for leading companies in open science.
The role of third-party entities
Third-party solutions are very promising. Public databases and search engines, like antibodypedia and The Antibody Registry, have been generated to compile data and comments on antibodies and other reagents. The Antibody Registry applies research resource identifiers (RRIDs) to identify unique antibodies.
The need for an independent, transparent antibody char- acterization entity led to YCharOS, a public interest organization owned by the non-profit Agora Open Science Trust. Led by prominent researchers, YCharOS assesses the performance of commercial antibodies for immunoblot, immunofluorescence, and immunoprecipitation applications using standardized operating procedures and knockout cells as negative controls. Twelve leading manufacturers supply requested antibodies for testing, up from seven at its 2021 launch. Reports on every antibody tested are published in the public domain without restriction or influence. Both manufacturers and researchers benefit from the dissem- ination of comprehensive antibody characterization data generated by an independent third party.
Problems surrounding transparency and reproducibility impact the scientific community as a whole. Transparency in commercial kits and reagents presents challenges, but successes from coordinated efforts between researchers, suppliers, and third parties demonstrate potential for fur- ther improvements.
"While commercial organizations must protect intellectual property and appease stakeholders, publishing non-sensitive information regarding reagents would benefit research and expand usability."
Product Spotlight
Revolutionizing Cancer Research: ATCC's HCMI Models
The Human Cancer Models Initiative (HCMI) is an international consortium dedicated to generating novel human tumor-derived culture models. Available exclusively through ATCC, these models, including organoids, encompass common and rare cancers from various tissues, such as primary, metastatic, and recurrent cancer. Each model's associated genomic and patient clinical data are also available to the research community, providing valuable tools
for studying cancer, identifying novel therapies, and facilitating translational cancer research. Discover more at ATCC!
Tips for Selecting Reputable Reagent Vendors
Ensuring quality and integrity in every experiment
by Sarah Kirsh, MSc
Selecting a reputable reagent supplier is a fundamental part of a lab manager's responsibilities, as the integrity and quality of lab reagents can directly impact experimental accuracy and reliability. Thith the market brimming with different vendors, discerning the good from the bad is more critical than ever.
Below are four essential tips to help you make an informed decision and protect your lab from unreliable sources.
Evaluate the vendor's track record and transparency
Signs of a reputable vendor: Many labs prefer vendors with a long-standing presence in the industry and a proven track record of customer satisfaction. The success and stability of these vendors in the market indicate their commitment to providing high-quality products and reliable services. Posi- tive customer feedback and reviews on the vendor's website or other online platforms can also provide confidence in
the supplier. Additionally, it's advisable to look for suppliers whose products have been cited in peer-reviewed research articles, as these citations can help validate the effectiveness and reliability of their products.
Red flags: A vendor lacking a substantial history or showing a pattern of inconsistent product quality should be ap- proached with caution. New entrants to the market without verifiable testimonials or endorsements from the scientific community may also pose a risk. Additionally, suppliers with a history of frequent business rebranding or those subject to customer complaints may indicate underlying issues with their products or business practices.
Assess scientific support and customer service
Signs of a reputable vendor: Excellent customer service and accessible scientific support are hallmarks of a trust- worthy supplier. This includes prompt and detailed re- sponses to inquiries, troubleshooting support, and access to scientific support staff who can advise on product selection and use. Effective customer service can also greatly reduce downtime, resulting in enhanced productivity.
Red flags: Vendors that are slow to respond, provide vague answers, or lack knowledgeable support staff are indicators of an unreliable vendor.
Verify quality control measures, certifications, and documentation
Signs of a reputable vendor: A reputable vendor should willingly share product documentation, including product specifications, certificates of analysis (COA), and safety data sheets (SDSs). They should also be committed to rigorous quality control measures through cGMP compliance and ISO accreditation.
Red flags: Suppliers lacking transparency in their quality processes and those unable or unwilling to present current certifications, product specifications, COA, and SDSs signal potential quality issues. Thithout proper documentation, it is difficult to verify the consistency and reliability of reagents.
Consider the breadth and depth of their product portfolio
Signs of a reputable vendor: A vendor with a diverse product catalog can indicate a well-established company that understands the diverse needs of research labs. This simpli- fies the procurement process and ensures consistency across experiments. However, these companies must demonstrate depth of expertise in the areas they cover. Evidence of this includes specialized product lines, published studies featur- ing their products, or comprehensive technical support. On the other hand, vendors specializing in a specific indus-
try segment can offer unparalleled expertise and deliver high-quality, innovative solutions not found with more generalized vendors.
Red flags: Vendors attempting to offer an excessively large range of products without demonstrating substantial depth or expertise might compromise quality. This can lead to
a "jack of all trades, master of none" situation, where the breadth of offerings is not matched by quality.
Key takeaways
Ultimately, lab managers should prioritize vendors with a reputation for customer satisfaction, accessible scientific support, and transparent quality control, along with a com- prehensive product range to uphold experimental integrity and quality.
Best Practices for Choosing and Validating Reagents
Knowing where to get reagents and how to validate them can save time and money while improving output
by Andy Tay, PhD and Angelo DePalma, PhD
Most experiments require chemicals and reagents unless they are fully computational. Choosing the right materials and knowing where to get them can significantly improve research efficiency. It can also help save money and time by avoiding extensive troubleshooting and ensuring the repro- ducibility of data.
Popularity of reagents
Lab managers should thoroughly research the popularity and reliability of reagents before making a purchase. One effective method is to check suppliers' websites to see if their products have been cited in peer-reviewed publications. The methods sections of these papers are valuable resources for
identifying specific brands and even batches of products, which is particularly important for biological reagents that can vary widely in composition and performance. By choos- ing widely recognized and validated reagents lab managers can increase the likelihood of achieving successful and reproducible results.
Quality and performance considerations
Thhile consumers take pleasure in price-shopping, that strategy works only when selecting among vendors that carry identical goods from the same manufacturer, like the latest cell phone or designer perfume. Biological reagents, even those with the same chemical name or product designa- tion, are unique. They are extracted or isolated from living organisms whose cultivation and source may differ. Man- ufacturing differences also cannot be underestimated. As producers of biological drugs like to say, "The product is the process." Products may differ noticeably, even when standard production methods are employed between different groups at different locations, and seemingly trivial excursions from SOPs can lead to products of differing quality and perfor- mance. That is why, for biological reagents, value, not price, is the operative word.
For applications like nanoparticle synthesis, purity is espe- cially crucial, as even minor contaminants can affect yield and quality. For biological reagents, like antibodies, reduced specificity due to batch-to-batch variability or antibodies that bind the wrong target can result in data misinterpre- tation and wasted resources. Therefore, checking whether your reagents have the necessary purity and specificity is important.
There are a few simple ways to validate antibodies:
Request characterization information: Obtain informa- tion regarding the antibody batch from the manufacturer.
Seek assistance: Engage with the scientific community and perform literature searches for publications that have used the same antibody.
Perform lab tests: Conduct simple tests using positive and negative controls. Examples include using cells with a knock-out gene expressing the antigen of interest or using siRNA to block the mRNA translation of the target antigen.
"When selecting reagents, it's important to consider more than
just the price."
Lab managers should aim to use reagents that come with comprehensive product data and have a proven track record of quality. Focusing on these factors ensures that the chosen reagents meet the necessary standards for reliability and performance in your specific research application.
Compatibility with experiments
Even if a product is popular and from a reputable source, it does not mean it is always the right choice. For example, an ELISA kit with detection limits in the nano-molar range
is inappropriate for experiments that generate molecular concentration in the pico-molar range. Additionally, choosing reagents that are validated for your specific application can enhance reliability. Therefore, lab managers must consider ex- perimental needs and existing lab facilities when purchasing reagents. To simplify the decision-making process, requesting a sample before committing to a purchase can be helpful.
Delivery concerns
Thith rising transport costs and delays in shipping, supply chains can become disrupted. Lab managers should consider this, as delivery delays may affect the stability of products and the integrity of experimental outcomes. Additionally, delayed deliveries can slow troubleshooting and optimiza- tion processes, as researchers cannot quickly test different products and identify the most suitable one. Because of this, it can be beneficial to purchase reagents from a nearby man- ufacturer with shorter delivery times. This may also reduce the hassle of customs delays, especially for toxic chemicals or potentially harmful biological items that require special packaging, handling, and licenses to possess.
Selecting the right products and suppliers is crucial for lab managers aiming to enhance their team's productivity. To make informed and effective purchasing decisions, lab man- agers must thoroughly evaluate the popularity and quality of reagents, understand experimental needs, and consider delivery times.
How to Select the Right Antibodies for Your Research
Antibody choice must consider the application, target, species, and validation methods for the best possible chance of success and reproducibility
by Brandoch Cook, PhD
Antibodies are some of the most powerful tools in the life sciences. The ability to single out one antigen of one partic- ular protein in a species- and context-specific manner from the hundreds of thousands known, and seemingly infinite number possible, is profound. However, the options available can be bewildering and fraught with complications, leading to scientific dead ends.
A stringent approach to antibody selection can (1) leverage the power of the chosen application to achieve sound results, and (2) avoid pitfalls inherent in the variety of hosts, clonali- ties, preparations, and validation parameters that contribute to the growing reproducibility crisis.
Thhen choosing antibodies, the investigator should address, at a minimum, the following questions:
What is the application?
An application benefits from, and often requires, a specific antibody variant or preparation. Common antibody-based applications include western blotting, ELISA, immunofluo- rescence, flow cytometry, immunohistochemistry (IHC), and immunoprecipitation.
An antibody that only recognizes its target antigen on a denatured protein is potentially suitable for western blotting, enabling the assessment of overall expression. Alternatively, an antibody that recognizes an antigen in its native state is more suited to immunofluorescence and assessing subcellu- lar localization.
Some IHC antibodies are optimized for unfixed frozen tis- sue, while others are compatible with fixed paraffin-embed- ded tissue and require an additional antigen retrieval step to reveal the relevant immunogen.
Is the antibody validated for the application of interest?
It is almost always better to use an antibody that has been extensively validated for your application rather than a general-purpose antibody with reported success in other ap- plications. Commercial antibody specification sheets should indicate, with evidence in the form of high-quality images and suggested dilution ranges, for which applications their product has been validated. Suppliers should also cite recent literature in which the product has been used. This is usually
a valuable resource for the investigator to formulate specific protocols and serves as additional external validation.
In the absence of thorough validation, the user may have to perform additional complex steps, including key controls, to satisfy peer-review guidelines when optimizing an applica- tion and preparing a study for publication.
Antibodies for applications with high validation standards (such as chromatin immunoprecipitation) can often work in applications with lower standards (such as western blotting), but not the other way around.
What is the exact target of interest?
Individual proteins often have multiple confounding names, sometimes with many isoforms and post-translational mod- ifications. Databases such as UniProt can narrow searches ap- propriately. Moreover, knowing the biology of your protein (Is it a nuclear transcription factor? A cell-membrane recep- tor? A kinase that is actively phosphorylated and de-phos- phorylated?) is crucial to finding the right product.
You must also know how the antibody was raised. Thas it raised against a specific epitope or the whole protein? If the former, is the epitope available to be recognized in your application? If the latter, is the antibody cross-specific for other isoforms? Are you trying to detect a rare endogenous protein, a ubiquitous and highly expressed protein, or a tagged and exogenously expressed construct?
What species and sample types are being investigated?
If you are studying a human or mouse protein, at least one validated commercial antibody is typically available. How- ever, standard research model organisms such as chicken, zebrafish, and Xenopus have a comparatively poor menu of antibodies. Cross-specific detection is sometimes possible, but it is always dependent on the degree of interspecific ho- mology at the epitope against which the antibody was raised.
What host species and antibody types are optimal?
The species in which an antibody was raised should differ from the one used to generate your biological sample to avoid cross-reactivity with endogenous immunoglobulin
molecules. Hence, one usually sees label qualifiers such as "RαM," meaning a rabbit anti-mouse antibody.
Polyclonal antibodies, often raised in rabbits, are usually lower-cost options that give strong, reproducible signals, but may be prone to non-specific background or multiple confounding bands. Monoclonal antibodies, often raised in mice, are homogeneous preparations recognizing a single epitope and are therefore highly specific, but they may vary from lot to lot. Recombinant monoclonals raised in host cell cultures provide the highest degree of specificity via precise definition of their DNA sequences.
What detection method is being used?
Antibody-based applications usually proceed by detection of a chromogenic, fluorescent, or luminescent signal gener- ated by (1) binding of the protein-specific primary antibody to a host species-matched general secondary antibody, and
(2) activation of the material conjugated to the secondary antibody-usually an enzyme that acts upon a substrate, or a fluorophore that emits light.
Primary antibodies conjugated to fluorophores are com- monly used for direct detection in flow cytometry. However, conjugated secondaries are more sensitive, versatile, and cost-effective in most applications.
How suitable is the antibody to combinations with others for multiplexing?
Direct co-detection of multiple proteins with conjugated primary antibodies is common in flow cytometry. However, the emission spectra of different fluorophores may overlap or extend into different channels beyond the capability to correct signals via compensation.
For secondary antibody-based multiplexing in other applica- tions, antibodies raised in different species must be used and should recognize the designated species exclusively.
Answering these questions to formulate a firm plan is the first step in purchasing antibodies with the best chance of obtaining reliable results. Understanding a target protein's biology, knowing the sample type and species, and assessing the degree of validation within your application of interest will inevitably lead in the right direction. But when in doubt, ask for a trial size.
Considerations for Acquiring Custom Kits
A carefully chosen custom kit can help labs better meet their needs
by Andy Tay, PhD
Researchers are working to solve diverse challenges, neces- sitating a variety of tools. Thhile most kits are designed to meet broad research needs, custom solutions are sometimes required. Here, we will explore the key considerations for purchasing custom kits.
Complex manufacturing
Manufacturing research kits, even the most common ones, is a complex process. For example, producing primary antibod-
ies requires access to different animal models, which can be time-consuming and cost-prohibitive for many labs. Cus- tom kits are invaluable in such scenarios, as manufacturers have the infrastructure to produce the required materials efficiently. Using custom kits also boosts research productiv- ity, allowing staff to focus on scientific inquiry rather than refining the production process.
Another advantage of ordering custom kits is the scale that suppliers can provide. Manufacturers are equipped to
"When purchasing custom kits, it is recommended that labs maintain continual communication with their suppliers to ensure the kit meets their research objectives."
produce large quantities of kits quickly and reliably, which is often challenging for individual labs. This capacity ensures that researchers have a consistent supply of high-quality ma- terials, reducing the risk of delays due to production issues.
Quality control and reproducibility
Many biological reagents are sensitive to environmental fluctuations, meaning their function can be compromised if not properly handled. Custom kit manufacturers often offer superior quality control compared to in-lab produc-
tion, ensuring reagents maintain functionality. Additionally, custom kits commonly include pre-aliquoted components
at precisely measured volumes, minimizing handling errors and reducing the risk of cross-contamination for enhanced sample integrity.
A good example is the design of nanoparticles, which track specific RNA in cells. This area is of great interest as researchers aim to understand how the spatial distribution of RNA in a cell may affect processes like cell division. To test this, nanoparticles are designed with anti-sense RNA
that binds to the target RNA and, upon binding, produces a fluorescent signal. Since there are many types of RNA with different functions, custom kits are usually required. For some target RNAs of low abundance, having a custom kit with RNA-binding nanoparticles, combined with high-qual- ity control, can greatly improve reproducibility.
Flexibility
For manufacturing, suppliers often develop processes that can be applied to different custom kits. For instance, to gen- erate a nanoparticle that binds to RNA, manufacturers may only need to change the sequence of the anti-sense RNA, enabling them to use the same platform to produce many types of custom kits. However, for less experienced labs, it may take a long time to develop the underlying production technology, which may not be widely applicable.
Costs
Thhen buying lab reagents, cost is a major factor to consider. Thhile custom kits may seem expensive at first, they can be more cost-effective in the long run compared to general-pur- pose kits, especially when labs factor in the costs of making the materials in-house. Custom kits are also convenient as they arrive ready to use, which ensures that research pro- gresses as planned, ultimately resulting in long-term savings.
To help labs afford custom kits, many manufacturers offer different payment models. For instance, labs can pay based on performance, known as outcome-based payment. Another
option is staggered payments: half when placing the order and half upon successful performance. These models protect the interests of lab users and motivate manufacturers to deliver high-quality, functional products.
Key takeaways
Thhen purchasing custom kits, it is recommended that labs maintain continual communication with their suppliers to ensure the kit meets their research objectives. Labs should also choose manufacturers that can provide proof of quality and of- fer flexible payment models. This helps ensure that custom kits support research objectives and enhance overall productivity.
Navigating the Common Chemical and Reagent Grades
Knowing which grade is right for you can make a big difference in quality, safety, and cost
Understanding the different chemical and reagent grades is crucial for ensuring the accuracy and reliability of scientific experiments. These grades are separated based on their purity and intended use. For example, ACS grades are ideal for any application that requires stringent quality specifications.
Choosing the right grade for your application requires careful consideration of several factors, including the purpose of the experiment, the required purity levels, regulatory requirements, and costs. In highly regulated fields, like food
and pharmaceuticals, using a grade that is too low can lead to noncompliance and safety issues. On the other hand, excessive purity can result in unnecessary expenditure. By thoroughly assessing an application's requirements and understanding the range of available grades, researchers can make informed decisions that balance quality and cost-efficiency, ensuring optimal outcomes for their work.
ATCC is the premier global biological materials resource and standards organization. Its mission focuses on acquiring, authenticating, producing, preserving, developing, and distributing standard reference microorganisms, cell lines, and other materials. While maintaining traditional collection materials, ATCC develops high-quality advanced biological models, standards, and services to support scientific research and breakthroughs that improve the health of global populations.
In partnership with